Inside Precision Medicine

A new whole-genome CRISPR screening platform has helped researchers identify a previously unknown gene causing lymphoma cells to become resistant to a widely used cancer drug, as well as several genes that can accelerate tumor growth. Published today in Science Advances, ...

Mutations in the tumor suppressor TP53 are among the most common genetic alterations in cancer, making mutant p53 an attractive target for personalized immunotherapies. However, new research suggests that identifyi...

Preventative care is well established as the goal to maintaining a long and healthy life. A multitude of advice and recommendations on lifestyle choices are available, including establishing regular visits with clinicians to track health. However, while patients may seek medical advice for healthy living or treatment for disease, identifying precursors to disease symptoms is ...

An AI system that coordinates computerized “scientist” agents under a virtual chief scientific officer could speed the discovery of new therapeutic drugs.

The Virtual Biotech multi-agent AI research platform combines wide-ranging biomedical and clinical evidence to support early-stage drug development systems.

Around nine in every 10 drug candidates currently en...

Routine blood tests may reveal hidden warning signs of cancer in patients with non-specific symptoms such as unexplained weight loss. In a study published in PLOS Medicine, researchers at the University of Oxford report that tracking how blood test results change over time may offer impor...